ADHD Treatments Under the Spotlight: Weighing Benefits and Harms
November 28, 2025
Background
Aniridia is a condition where the iris (colored part around pupil) is missing partially or fully. Some people develop it later from trauma or surgery. But others are born with it, called congenital aniridia, affecting both eyes. Most congenital cases are inherited in an autosomal dominant pattern. But some irregular congenital aniridia cases occur sporadically, like with WAGR syndrome. This rare disorder involves Wilms tumor, aniridia, genital abnormalities, and intellectual disability. Gillespie syndrome is another rare, recessively inherited form with aniridia, ataxia, and intellectual disability. Scientists linked congenital aniridia to mutations in the PAX6 gene on chromosome 11p13. Acquired aniridia occurs following surgery or trauma to the eyes.
Epidemiology
Approximately 1,800 babies out of every 100 million newborns experience aniridia. Gender plays no significant role as it affects men and women in a similar way.
Anatomy
Pathophysiology
The cause of congenital aniridia has been connected to several genes. Aniridia 1 or AN1 (OMIM # 106210) results from a mutation in the PAX6 gene on chromosome 11p13. It is inherited in an autosomal dominant pattern. Other features may include congenital cataracts, late onset corneal dystrophy, absence of the pineal gland, underdeveloped corpus callosum or anterior commissure, reduced sense of smell, and Peters anomaly. A different mutation, in a regulatory region near the ELP4 gene’s intron on 11p13, leads to Aniridia 2 (AN2) (OMIM # 617141. TRIM44 gene mutations on 11p13 cause Aniridia 3 (AN3) (OMIM # 617142), an autosomal dominant disorder as aniridia 2. The ITPR1 gene on 3p26.1, when mutated, results in Gillespie syndrome (OMIM # 206700). Some studies suggest that autosomal dominant aniridia may connect to the acid phosphatase 1 (ACP1) gene on chromosome 2p.
Etiology
The most important reason for congenital aniridia is the paired box gene or PAX6 found on chromosome 11p13. This uncommon genetic disorder affects the development of key body parts during the embryo stage. Theories suggest that it may relate to abnormalities in the mesoderm, neuroectoderm, or iris coloboma. Congenital aniridia can be categorized as sporadic, autosomal recessive, or autosomal dominant condition. Autosomal dominant is most common in up to 85% of cases. Sporadic congenital aniridia results from a new gene mutation, sometimes linked to nephroblastoma and WAGR syndrome. The rarest form, autosomal recessive aniridia, is associated with mental delays and impaired coordination of cerebellum. Still, the precise cause behind aniridia remains unclear.
Genetics
Prognostic Factors
Clinical History
Aniridia causes vision problems from birth. Common signs include decreased eyesight, involuntary eye movements, sensitivity to light, crossed eyes, and missing iris. Reviewing family medical records for developmental delays, hearing issues, belly button positioning, digestive problems, and eye abnormalities is crucial. A thorough, multisystem evaluation is essential for proper diagnosis.
Physical Examination
Slit lamp flash images show fine details like the depth of the anterior eye chamber, zonular fibers connecting the crystalline lens to the ciliary body, cloudy spots on the lens (lenticular opacities), cloudy spots on the cornea (corneal opacities), and the edge of a dislocated but transparent lens. Especially in children, these images help to track tissue changes over time. Besides aniridia associated keratopathy, the patient may show symptoms like abnormally small cornea (microcornea), premature arcus clouding around the cornea’s periphery (arcus juvenilis), involuntary eye movements (nystagmus), misaligned eyes (strabismus), light sensitivity (photophobia), corneal surface inflammation with blood vessel growth (pannus), and sores on the cornea’s outermost layer (epithelial ulcers). Depending on the position of the crystalline lens, the arrangement inside the anterior chamber varies. Sometimes, there is no iris at all, other times, it appears underdeveloped with irregular pupil margins. The iris root, or stump, may hide part or all of the drainage angle of the anterior chamber, when viewed through a specialized lens (gonioscopy).
Age group
Associated comorbidity
Aniridia can be complicated due to
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Correction of refractive errors: Aniridia patients frequently experience refractive errors. Their eyes commonly have conditions like nearsightedness, farsightedness, or astigmatism. However, prescribed glasses or contact lens can correct these vision issues, enhancing visual clarity.
Management of photophobia: Light sensitivity, also known as photophobia, is a frequent issue for people with aniridia. They often find bright spaces uncomfortable. To make things easier, wearing tinted or polarized lenses can help reduce glare. In addition, having a wide brimmed hat or sunglasses with extra coverage provides more light protection and relief from bright conditions.
Treatment of nystagmus: Nystagmus is an involuntary, rhythmic eye movement. It impacts vision clarity a lot. There is no cure for nystagmus yet. However, some medicines may help reduce eye movements for some people. Anti-seizure drugs like gabapentin or muscle relaxants such as baclofen could help. Vision therapy exercises may also improve eye stability and control.
Surgical interventions: Aniridia patients may require surgeries for complications. Possibilities include:
Cataract surgery removes cloudy lenses, restoring vision. Aniridia raises cataract risk at younger ages due to abnormal eye development.
Keratoplasty transplants corneas for thinning (keratopathy) or scarring, improving transparency and vision. Corneal issues can occur with aniridia.
Glaucoma management treats increased eye pressure damaging optic nerves and increasing risk of vision loss. Glaucoma is more common with aniridia. Treatment options may include medications, laser therapy, surgeries like trabeculectomy or drainage implants.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Administration of non-pharmaceutical agents for treating aniridia
Protective eye wear:
For people with aniridia, specialized eyewear provides relief from challenges. Tinted or polarized lenses reduce glare, helping eyes to feel comfortable in bright places. Glasses or contact lens fix vision problems. Wearing hats or wraparound sunglasses offers protection from the sun. These block harsh rays, minimizing discomfort. As a result, outdoor activities become more convenient.
Vision therapy: For improving vision stability, coordination, and perceÂption in aniridia patients, vision therapy methods might geÂt used. A skilled vision therapist direÂcts these exeÂrcises. They work to boost visual abilities. TheÂy help ease symptoms like nystagmus and depth insight problems.
Assistive devices: Individuals living with aniridia have access to support devices. Simple tools like magnifiers help improve reduced vision. Also, audio technology assists with reading digital content and navigation. Other low-vision aids compensate for vision challenges in everyday tasks.
Modification of the environment: People with aniridia face visual challenges. Simple changes at home and work can make things easier for them. Brighter lights help them see better. Reducing harsh glare from windows or lamps is important too. Moving furniture or objects out of the way prevents bumping into things. These basic accommodations aid navigation and performing tasks more safely.
Administration of pharmaceutical agents for treating aniridia
intervention-with-a-procedure
use-of-phases-of-management-in-treating-aniridia
Medication
Future Trends
Aniridia is a condition where the iris (colored part around pupil) is missing partially or fully. Some people develop it later from trauma or surgery. But others are born with it, called congenital aniridia, affecting both eyes. Most congenital cases are inherited in an autosomal dominant pattern. But some irregular congenital aniridia cases occur sporadically, like with WAGR syndrome. This rare disorder involves Wilms tumor, aniridia, genital abnormalities, and intellectual disability. Gillespie syndrome is another rare, recessively inherited form with aniridia, ataxia, and intellectual disability. Scientists linked congenital aniridia to mutations in the PAX6 gene on chromosome 11p13. Acquired aniridia occurs following surgery or trauma to the eyes.
Approximately 1,800 babies out of every 100 million newborns experience aniridia. Gender plays no significant role as it affects men and women in a similar way.
The cause of congenital aniridia has been connected to several genes. Aniridia 1 or AN1 (OMIM # 106210) results from a mutation in the PAX6 gene on chromosome 11p13. It is inherited in an autosomal dominant pattern. Other features may include congenital cataracts, late onset corneal dystrophy, absence of the pineal gland, underdeveloped corpus callosum or anterior commissure, reduced sense of smell, and Peters anomaly. A different mutation, in a regulatory region near the ELP4 gene’s intron on 11p13, leads to Aniridia 2 (AN2) (OMIM # 617141. TRIM44 gene mutations on 11p13 cause Aniridia 3 (AN3) (OMIM # 617142), an autosomal dominant disorder as aniridia 2. The ITPR1 gene on 3p26.1, when mutated, results in Gillespie syndrome (OMIM # 206700). Some studies suggest that autosomal dominant aniridia may connect to the acid phosphatase 1 (ACP1) gene on chromosome 2p.
The most important reason for congenital aniridia is the paired box gene or PAX6 found on chromosome 11p13. This uncommon genetic disorder affects the development of key body parts during the embryo stage. Theories suggest that it may relate to abnormalities in the mesoderm, neuroectoderm, or iris coloboma. Congenital aniridia can be categorized as sporadic, autosomal recessive, or autosomal dominant condition. Autosomal dominant is most common in up to 85% of cases. Sporadic congenital aniridia results from a new gene mutation, sometimes linked to nephroblastoma and WAGR syndrome. The rarest form, autosomal recessive aniridia, is associated with mental delays and impaired coordination of cerebellum. Still, the precise cause behind aniridia remains unclear.
Aniridia causes vision problems from birth. Common signs include decreased eyesight, involuntary eye movements, sensitivity to light, crossed eyes, and missing iris. Reviewing family medical records for developmental delays, hearing issues, belly button positioning, digestive problems, and eye abnormalities is crucial. A thorough, multisystem evaluation is essential for proper diagnosis.
Slit lamp flash images show fine details like the depth of the anterior eye chamber, zonular fibers connecting the crystalline lens to the ciliary body, cloudy spots on the lens (lenticular opacities), cloudy spots on the cornea (corneal opacities), and the edge of a dislocated but transparent lens. Especially in children, these images help to track tissue changes over time. Besides aniridia associated keratopathy, the patient may show symptoms like abnormally small cornea (microcornea), premature arcus clouding around the cornea’s periphery (arcus juvenilis), involuntary eye movements (nystagmus), misaligned eyes (strabismus), light sensitivity (photophobia), corneal surface inflammation with blood vessel growth (pannus), and sores on the cornea’s outermost layer (epithelial ulcers). Depending on the position of the crystalline lens, the arrangement inside the anterior chamber varies. Sometimes, there is no iris at all, other times, it appears underdeveloped with irregular pupil margins. The iris root, or stump, may hide part or all of the drainage angle of the anterior chamber, when viewed through a specialized lens (gonioscopy).
Aniridia can be complicated due to
Correction of refractive errors: Aniridia patients frequently experience refractive errors. Their eyes commonly have conditions like nearsightedness, farsightedness, or astigmatism. However, prescribed glasses or contact lens can correct these vision issues, enhancing visual clarity.
Management of photophobia: Light sensitivity, also known as photophobia, is a frequent issue for people with aniridia. They often find bright spaces uncomfortable. To make things easier, wearing tinted or polarized lenses can help reduce glare. In addition, having a wide brimmed hat or sunglasses with extra coverage provides more light protection and relief from bright conditions.
Treatment of nystagmus: Nystagmus is an involuntary, rhythmic eye movement. It impacts vision clarity a lot. There is no cure for nystagmus yet. However, some medicines may help reduce eye movements for some people. Anti-seizure drugs like gabapentin or muscle relaxants such as baclofen could help. Vision therapy exercises may also improve eye stability and control.
Surgical interventions: Aniridia patients may require surgeries for complications. Possibilities include:
Cataract surgery removes cloudy lenses, restoring vision. Aniridia raises cataract risk at younger ages due to abnormal eye development.
Keratoplasty transplants corneas for thinning (keratopathy) or scarring, improving transparency and vision. Corneal issues can occur with aniridia.
Glaucoma management treats increased eye pressure damaging optic nerves and increasing risk of vision loss. Glaucoma is more common with aniridia. Treatment options may include medications, laser therapy, surgeries like trabeculectomy or drainage implants.
Ophthalmology
Protective eye wear:
For people with aniridia, specialized eyewear provides relief from challenges. Tinted or polarized lenses reduce glare, helping eyes to feel comfortable in bright places. Glasses or contact lens fix vision problems. Wearing hats or wraparound sunglasses offers protection from the sun. These block harsh rays, minimizing discomfort. As a result, outdoor activities become more convenient.
Vision therapy: For improving vision stability, coordination, and perceÂption in aniridia patients, vision therapy methods might geÂt used. A skilled vision therapist direÂcts these exeÂrcises. They work to boost visual abilities. TheÂy help ease symptoms like nystagmus and depth insight problems.
Assistive devices: Individuals living with aniridia have access to support devices. Simple tools like magnifiers help improve reduced vision. Also, audio technology assists with reading digital content and navigation. Other low-vision aids compensate for vision challenges in everyday tasks.
Modification of the environment: People with aniridia face visual challenges. Simple changes at home and work can make things easier for them. Brighter lights help them see better. Reducing harsh glare from windows or lamps is important too. Moving furniture or objects out of the way prevents bumping into things. These basic accommodations aid navigation and performing tasks more safely.
Ophthalmology
Ophthalmology
Ophthalmology
Aniridia is a condition where the iris (colored part around pupil) is missing partially or fully. Some people develop it later from trauma or surgery. But others are born with it, called congenital aniridia, affecting both eyes. Most congenital cases are inherited in an autosomal dominant pattern. But some irregular congenital aniridia cases occur sporadically, like with WAGR syndrome. This rare disorder involves Wilms tumor, aniridia, genital abnormalities, and intellectual disability. Gillespie syndrome is another rare, recessively inherited form with aniridia, ataxia, and intellectual disability. Scientists linked congenital aniridia to mutations in the PAX6 gene on chromosome 11p13. Acquired aniridia occurs following surgery or trauma to the eyes.
Approximately 1,800 babies out of every 100 million newborns experience aniridia. Gender plays no significant role as it affects men and women in a similar way.
The cause of congenital aniridia has been connected to several genes. Aniridia 1 or AN1 (OMIM # 106210) results from a mutation in the PAX6 gene on chromosome 11p13. It is inherited in an autosomal dominant pattern. Other features may include congenital cataracts, late onset corneal dystrophy, absence of the pineal gland, underdeveloped corpus callosum or anterior commissure, reduced sense of smell, and Peters anomaly. A different mutation, in a regulatory region near the ELP4 gene’s intron on 11p13, leads to Aniridia 2 (AN2) (OMIM # 617141. TRIM44 gene mutations on 11p13 cause Aniridia 3 (AN3) (OMIM # 617142), an autosomal dominant disorder as aniridia 2. The ITPR1 gene on 3p26.1, when mutated, results in Gillespie syndrome (OMIM # 206700). Some studies suggest that autosomal dominant aniridia may connect to the acid phosphatase 1 (ACP1) gene on chromosome 2p.
The most important reason for congenital aniridia is the paired box gene or PAX6 found on chromosome 11p13. This uncommon genetic disorder affects the development of key body parts during the embryo stage. Theories suggest that it may relate to abnormalities in the mesoderm, neuroectoderm, or iris coloboma. Congenital aniridia can be categorized as sporadic, autosomal recessive, or autosomal dominant condition. Autosomal dominant is most common in up to 85% of cases. Sporadic congenital aniridia results from a new gene mutation, sometimes linked to nephroblastoma and WAGR syndrome. The rarest form, autosomal recessive aniridia, is associated with mental delays and impaired coordination of cerebellum. Still, the precise cause behind aniridia remains unclear.
Aniridia causes vision problems from birth. Common signs include decreased eyesight, involuntary eye movements, sensitivity to light, crossed eyes, and missing iris. Reviewing family medical records for developmental delays, hearing issues, belly button positioning, digestive problems, and eye abnormalities is crucial. A thorough, multisystem evaluation is essential for proper diagnosis.
Slit lamp flash images show fine details like the depth of the anterior eye chamber, zonular fibers connecting the crystalline lens to the ciliary body, cloudy spots on the lens (lenticular opacities), cloudy spots on the cornea (corneal opacities), and the edge of a dislocated but transparent lens. Especially in children, these images help to track tissue changes over time. Besides aniridia associated keratopathy, the patient may show symptoms like abnormally small cornea (microcornea), premature arcus clouding around the cornea’s periphery (arcus juvenilis), involuntary eye movements (nystagmus), misaligned eyes (strabismus), light sensitivity (photophobia), corneal surface inflammation with blood vessel growth (pannus), and sores on the cornea’s outermost layer (epithelial ulcers). Depending on the position of the crystalline lens, the arrangement inside the anterior chamber varies. Sometimes, there is no iris at all, other times, it appears underdeveloped with irregular pupil margins. The iris root, or stump, may hide part or all of the drainage angle of the anterior chamber, when viewed through a specialized lens (gonioscopy).
Aniridia can be complicated due to
Correction of refractive errors: Aniridia patients frequently experience refractive errors. Their eyes commonly have conditions like nearsightedness, farsightedness, or astigmatism. However, prescribed glasses or contact lens can correct these vision issues, enhancing visual clarity.
Management of photophobia: Light sensitivity, also known as photophobia, is a frequent issue for people with aniridia. They often find bright spaces uncomfortable. To make things easier, wearing tinted or polarized lenses can help reduce glare. In addition, having a wide brimmed hat or sunglasses with extra coverage provides more light protection and relief from bright conditions.
Treatment of nystagmus: Nystagmus is an involuntary, rhythmic eye movement. It impacts vision clarity a lot. There is no cure for nystagmus yet. However, some medicines may help reduce eye movements for some people. Anti-seizure drugs like gabapentin or muscle relaxants such as baclofen could help. Vision therapy exercises may also improve eye stability and control.
Surgical interventions: Aniridia patients may require surgeries for complications. Possibilities include:
Cataract surgery removes cloudy lenses, restoring vision. Aniridia raises cataract risk at younger ages due to abnormal eye development.
Keratoplasty transplants corneas for thinning (keratopathy) or scarring, improving transparency and vision. Corneal issues can occur with aniridia.
Glaucoma management treats increased eye pressure damaging optic nerves and increasing risk of vision loss. Glaucoma is more common with aniridia. Treatment options may include medications, laser therapy, surgeries like trabeculectomy or drainage implants.
Ophthalmology
Protective eye wear:
For people with aniridia, specialized eyewear provides relief from challenges. Tinted or polarized lenses reduce glare, helping eyes to feel comfortable in bright places. Glasses or contact lens fix vision problems. Wearing hats or wraparound sunglasses offers protection from the sun. These block harsh rays, minimizing discomfort. As a result, outdoor activities become more convenient.
Vision therapy: For improving vision stability, coordination, and perceÂption in aniridia patients, vision therapy methods might geÂt used. A skilled vision therapist direÂcts these exeÂrcises. They work to boost visual abilities. TheÂy help ease symptoms like nystagmus and depth insight problems.
Assistive devices: Individuals living with aniridia have access to support devices. Simple tools like magnifiers help improve reduced vision. Also, audio technology assists with reading digital content and navigation. Other low-vision aids compensate for vision challenges in everyday tasks.
Modification of the environment: People with aniridia face visual challenges. Simple changes at home and work can make things easier for them. Brighter lights help them see better. Reducing harsh glare from windows or lamps is important too. Moving furniture or objects out of the way prevents bumping into things. These basic accommodations aid navigation and performing tasks more safely.
Ophthalmology
Ophthalmology
Ophthalmology

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
